Alan V. Boddy

Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors

Ruth Plummer, Christopher J. Jones, Mark R. Middleton et al. · Clinical Cancer Research · 2008 · 380 citations · Full text

A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours

Ruth Plummer, Richard H. Wilson, Hilary Calvert et al. · British Journal of Cancer · 2011 · 378 citations · Full text

Phase I and pharmacokinetic study of d -limonene in patients with advanced cancer

David M. Vigushin, Grace K. Poon, Alan V. Boddy et al. · Cancer Chemotherapy and Pharmacology · 1998 · 240 citations

Advanced Cancer, Medicine, Pharmacology +7

Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide

Johanne Bray, J Sludden, Martin J. Griffin et al. · British Journal of Cancer · 2010 · 179 citations · Full text

Estimation of glomerular filtration rate in cancer patients

Jackson Wright, Alan V. Boddy, Martin Highley et al. · British Journal of Cancer · 2001 · 169 citations · Full text